191 related articles for article (PubMed ID: 19499093)
1. Review of available infertility treatments.
Hrometz SL; Gates VA
Drugs Today (Barc); 2009 Apr; 45(4):275-91. PubMed ID: 19499093
[TBL] [Abstract][Full Text] [Related]
2. [Intrauterine insemination: spontaneous or medically-assisted ovulation?].
Massin N; Cédrin-Durnerin I; Hugues JN
Gynecol Obstet Fertil; 2004 Oct; 32(10):898-903. PubMed ID: 15501170
[TBL] [Abstract][Full Text] [Related]
3. [Intrauterine insemination: state-of-the-art in humans].
Royère D
Gynecol Obstet Fertil; 2004 Oct; 32(10):873-9. PubMed ID: 15501166
[TBL] [Abstract][Full Text] [Related]
4. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of simultaneous use of cryopreserved semen, controlled ovarian hyperstimulation and intrauterine insemination in the treatment of sterility caused by hypergonadotropic azoospermia].
Kably Ambe A; Góngora Rodríguez A; Barrón Vallejo J; Olgúin Godínez A
Ginecol Obstet Mex; 1999 Feb; 67():53-7. PubMed ID: 10327765
[TBL] [Abstract][Full Text] [Related]
6. In vitro maturation for patients with polycystic ovary syndrome.
Reinblatt SL; Buckett W
Semin Reprod Med; 2008 Jan; 26(1):121-6. PubMed ID: 18181090
[TBL] [Abstract][Full Text] [Related]
7. Controlled ovarian hyperstimulation: a review for the non-ART patient.
Willis MY; Browne AS; Session DR; Spencer JB
Minerva Ginecol; 2011 Apr; 63(2):119-35. PubMed ID: 21508902
[TBL] [Abstract][Full Text] [Related]
8. Infertility and pregnancy in women with polycystic ovary syndrome.
Nader S
Minerva Endocrinol; 2010 Dec; 35(4):211-25. PubMed ID: 21178917
[TBL] [Abstract][Full Text] [Related]
9. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
10. Ovulation induction in the ovulatory woman.
Silverberg KM
Semin Reprod Endocrinol; 1996 Nov; 14(4):339-44. PubMed ID: 8988528
[TBL] [Abstract][Full Text] [Related]
11. [Medically assisted procreation. Main biological, medical and ethical aspects ].
Roux C; Berdin A; Amiot C
Rev Prat; 2014 Dec; 64(10):1435-44. PubMed ID: 25665331
[No Abstract] [Full Text] [Related]
12. [The role and place of the assisted reproductive technology (ART) in treatment of infertility].
Szamatowicz M
Ginekol Pol; 2007 Mar; 78(3):175-9. PubMed ID: 17650895
[TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
Kuang Y; Chen Q; Fu Y; Wang Y; Hong Q; Lyu Q; Ai A; Shoham Z
Fertil Steril; 2015 Jul; 104(1):62-70.e3. PubMed ID: 25956370
[TBL] [Abstract][Full Text] [Related]
14. Assisted reproductive technology surveillance--United States, 2000.
Wright VC; Schieve LA; Reynolds MA; Jeng G
MMWR Surveill Summ; 2003 Aug; 52(9):1-16. PubMed ID: 14532867
[TBL] [Abstract][Full Text] [Related]
15. [Intrauterine inseminations in women over 35: the pros].
Merviel P; Lourdel E; Cabry R; Brzakowski M; Dupond S; Boulard V; Demailly P; Brasseur F; Copin H; Devaux A
Gynecol Obstet Fertil; 2010 Apr; 38(4):283-9. PubMed ID: 20362484
[No Abstract] [Full Text] [Related]
16. Prospective study of a Swedish infertile cohort 2005-08: population characteristics, treatments and pregnancy rates.
Aanesen A; Westerbotn M
Fam Pract; 2014 Jun; 31(3):290-7. PubMed ID: 24591683
[TBL] [Abstract][Full Text] [Related]
17. The effects of timing of intrauterine insemination in relation to ovulation and the number of inseminations on cycle pregnancy rate in common infertility etiologies.
Ghanem ME; Bakre NI; Emam MA; Al Boghdady LA; Helal AS; Elmetwally AG; Hassan M; Albahlol IA; Elzayat MM
Hum Reprod; 2011 Mar; 26(3):576-83. PubMed ID: 21177312
[TBL] [Abstract][Full Text] [Related]
18. [From theory to clinical practice: recombinant FSH in daily practice].
Kably Ambe A; Barrón Vallejo J; Góngora Rodríguez A; Carballo Mondragón E; Anta Jaén E
Ginecol Obstet Mex; 1999 Aug; 67():408-13. PubMed ID: 10504796
[TBL] [Abstract][Full Text] [Related]
19. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of infertility treatments: choice and comparative analysis.
Hull MG
Int J Gynaecol Obstet; 1994 Nov; 47(2):99-108. PubMed ID: 7843496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
